Observational Study
Copyright ©The Author(s) 2017.
World J Clin Cases. Dec 16, 2017; 5(12): 412-418
Published online Dec 16, 2017. doi: 10.12998/wjcc.v5.i12.412
Table 1 Comparison of various factors before and after Helicobacter pylori eradication therapy in all subjects (n = 130)
VariableSubjectsMissingPre-eradication mean (SD)Post-eradication mean (SD)Mean difference95%CIP value
Body weight (kg)124657.3 (10.4)58.2 (10.3)0.520.09-0.940.018
BMI (kg/m2)121923.4 (3.1)23.7 (3.0)0.250.074-0.420.006
Hb (g/dL)1151513.8 (1.4)13.8 (1.3)0.018-0.350.84
MCV (fL)1131789.2 (4.9)90 (4.4)0.830.32-1.34< 0.001
TP (g/dL)90407.4 (0.5)7.5 (0.4)0.024-0.1680.56
LDL-C (mg/dL)10723114.3 (23.9)116.2 (25.0)1.20-8.120.55
TG (mg/dL)10723122 (70.5)126.6 (77.1)6.81-22.590.23
HbA1c (%)42886.2 (0.81)6.3 (0.75)0.057-0.3050.45
Table 2 Subgroup analysis of various factors before and after Helicobacter pylori eradication therapy in the group of patients > 65 years (n = 97)
VariableSubjectsMissingPre-eradication mean (SD)Post-eradication mean (SD)Mean difference95%CIP value
Body weight (kg)92557.1 (10.4)57.8 (10.3)0.41-1.0170.12
BMI (kg/m2)90723.6 (3.0)23.8 (3.1)0.21-0.41590.045
Hb (g/dL)851213.7 (1.5)13.7 (1.3)-0.02-0.40.84
MCV (fL)851289.2 (5.3)90.1 (4.7)0.95-1.170.0017
TP (g/dL)66317.5 (0.5)7.5 (0.4)0.011-0.2160.84
LDL-C (mg/dL)7720111.9 (21.2)114.2 (24.8)1.25-9.650.61
TG (mg/dL)7720116.7 (56.2)112.6 (44.8)-1.68-20.350.74
HbA1c (%)30676.4 (0.8)6.4 (0.7)0.013-0.350.88
Table 3 Differences in the eradication effect on the rate of increase in haemoglobin level between groups of patients with < haemoglobin 12.5 g/dL (n = 20) and patients with ≥ haemoglobin 12.5 g/dL (n = 96)
VariableSubjectsMissingPre-eradication mean (SD)Post-eradication mean (SD)Mean difference95%CIP value
Less than Hb 12.5 g/dL19111.5 (0.7)12.3 (1.0)0.850.22-1.480.017
More over Hb 12.5 g/dL961114.2 (1.1)14.1 (1.2)-0.15-0.15920.064